1-4 of 4
Monika Conchon, MD PhD
Close
Sort by
Journal Articles

The Efficacy and Tolerability of Generic of Imatinib in a Very Specific Group of Chronic Myeloid Leukemia (CML)

Monika Conchon, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5151.
https://doi.org/10.1182/blood.V126.23.5151.5151
Published: 2015
Journal Articles

Drug Toxicities in Second-Line Treatment of Chronic Myeloid Leukemia

Tarcila S Datoguia, MD, Hugo R C Silva, MD, Amauri M C R Junior, MD, José Salvador Oliveira, PhD, Monika Conchon, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5173.
https://doi.org/10.1182/blood.V126.23.5173.5173
Published: 2015
Journal Articles

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Monika Conchon, MD, PhD, Renato S Tavares, MD, Katia B. Pagnano, MD, PhD, Tarcila S Datoguia, MD, Israel Bendit, MD, PhD, Marcia Torresan Delamain, MD, Irene Lorand-Metze, MD, PhD, Danielle Leão, MD, Jose Salvador Rodrigues, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5255.
https://doi.org/10.1182/blood.V122.21.5255.5255
Published: 2013
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia with T315I BCR-ABL Mutation

Kati a BB Pagnano, MD, PhD, Rosana A Silveira, Luciana Nardinelli, Monika Conchon, MD, PhD, Carmino De Souza, MD, PhD, Pedro ED Llacer, MD, Phd, Irene Lorand-Metze, MD, PhD, Vaneuza Funke, MD, Ricardo Pasquini, MD, PhD, Cintia C Mascarenhas, Maria Aparecida Zanichelli, MD, Phd, Nelma CD Clementino, MD, PhD, Israel Bendit, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4262.
https://doi.org/10.1182/blood.V112.11.4262.4262
Published: 2008